Ozempic and NSAIDs (Ibuprofen, Naproxen): Drug Interaction Guide
HealthRX.com
Ozempic does not list NSAIDs, but the risks add up
Key numbers
- 36.4%Any GI reaction on Ozempic 1 mg in pooled type 2 diabetes trials, versus 15.3% on placeboSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 18.7%Kidney composite events on semaglutide 1 mg in FLOW (type 2 diabetes with CKD), versus 23.2% on placeboSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 1%Serious upper GI ulcer, bleeding or perforation in NSAID patients treated for 3 to 6 monthsSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 3,200 mgMaximum total daily dose of prescription ibuprofen, per the ibuprofen labelSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
At a glance
- Interaction type / Not listed on the Ozempic label; additive GI and kidney effects [1][2]
- NSAIDs on the Ozempic label / Not listed; the label's interaction section covers insulin, sulfonylureas and oral medicines in general [1]
- Ozempic GI reactions at 0.5 mg and 1 mg / Any GI reaction 32.7% and 36.4%, versus 15.3% on placebo [1]
- NSAID GI risk / Serious upper GI events in about 1% treated 3 to 6 months and 2% to 4% treated a year; one in five has symptoms [2]
- NSAID kidney risk / Highest with dehydration, diuretics, ACE inhibitors or ARBs, heart failure, kidney impairment and older age [2]
- NSAID use during anticoagulant treatment / Major bleeding 6.5 versus 2.0 per 100 patient-years without NSAID use [3]
- Semaglutide kidney outcome in FLOW / 18.7% versus 23.2% kidney composite events, 1 mg versus placebo, in type 2 diabetes with CKD [4]
Is there a direct interaction between Ozempic and ibuprofen or naproxen?
Ozempic is semaglutide, a GLP-1 receptor agonist given once weekly by injection; the label starts patients at 0.25 mg and steps up to 0.5, 1 or 2 mg [1]. It slows gastric emptying, and the label tells prescribers to use caution with oral medicines while noting that in clinical pharmacology trials semaglutide did not affect the absorption of oral medicines to any clinically relevant degree [1]. Semaglutide is broken down by proteolytic cleavage of its peptide backbone and beta-oxidation of its fatty acid side chain rather than by CYP enzymes, and the label describes a very low potential to inhibit or induce them [1]. Ibuprofen and naproxen work by blocking prostaglandin production [2].
Questions worth asking
Gastrointestinal risk: two separate problems in the same tract
The Ozempic label gives GI rates by dose. In pooled placebo-controlled trials in type 2 diabetes, any GI adverse reaction occurred in 15.3% on placebo, 32.7% on 0.5 mg and 36.4% on 1 mg; nausea in 6.1%, 15.8% and 20.3%; vomiting in 2.3%, 5% and 9.2%; diarrhea in 1.9%, 8.5% and 8.8% [1]. The label says Ozempic is not recommended in patients with severe gastroparesis [1].
The NSAID side is a different problem. The ibuprofen label carries a boxed warning that NSAIDs increase the risk of serious GI bleeding, ulceration and perforation, which can be fatal and can occur at any time without warning symptoms [2]. Serious upper GI ulcers, bleeding or perforation occurred in about 1% of patients treated for 3 to 6 months and 2% to 4% of those treated for a year, and only one in five patients who has a serious upper GI event has symptoms [2]. A past ulcer or GI bleed raises the risk more than 10-fold [2].
A meta-analysis of individual-participant data from NSAID trials shows the size of the NSAID contribution: upper GI complications were roughly four times more common with ibuprofen (rate ratio 3.97, 95% CI 2.22 to 7.10) or naproxen (4.22, 2.71 to 6.56) than with placebo [5].
Dr Paika on why ibuprofen and naproxen need caution on these injections
Dr Paika argues that NSAIDs such as ibuprofen and naproxen are a poor fit for someone taking Ozempic or Mounjaro. He says these painkillers already irritate the stomach lining and raise ulcer risk, and that the slower stomach emptying caused by these drugs means the painkiller stays in contact with the gut for longer. He also points to dehydration from nausea as an added strain on the kidneys and gut. In his view, acetaminophen is generally the safer first choice for occasional aches, as long as daily limits are respected, while any regular NSAID use should be discussed with the prescribing doctor rather than decided alone in a pharmacy aisle.
Who is speaking?
Dr. Mohammed Paika. Board-certified internal medicine and obesity medicine physician, as described on the channel Background
Kidney risk: dehydration on one side, prostaglandin blockade on the other
The Ozempic label has a specific warning here. It describes postmarketing reports of acute kidney injury, in some cases requiring hemodialysis, mostly in patients who had GI reactions causing dehydration such as nausea, vomiting or diarrhea, and says renal function should be monitored in patients reporting reactions that could lead to volume depletion, especially during dose initiation and escalation [1].
NSAIDs stress the kidney by a separate route. NSAID labels tie their kidney effects to inhibition of renal prostaglandin synthesis, and list the highest risk in people with impaired kidney function, dehydration, low blood volume, heart failure or liver dysfunction, in people taking diuretics, ACE inhibitors or ARBs, and in older adults [2]. Hyperkalemia has been reported with NSAIDs even without kidney impairment [2].
A separate study of people taking blood-pressure medicines found a higher rate of acute kidney injury when an NSAID was added to a diuretic plus an ACE inhibitor or ARB: rate ratio 1.31 (95% CI 1.12 to 1.53), rising to 1.82 (1.35 to 2.46) in the first 30 days, in a UK cohort of 487,372 antihypertensive users [6]. It did not measure the risk of combining an NSAID with Ozempic.
Semaglutide on its own was associated with fewer kidney events in FLOW, a trial of 3,533 adults with type 2 diabetes and chronic kidney disease: the composite kidney outcome occurred in 18.7% on semaglutide 1 mg versus 23.2% on placebo (HR 0.76, 0.66 to 0.88) [4].
Bleeding risk and what else stacks on top
- Anticoagulants. In 8,246 patients from the EINSTEIN venous thromboembolism trials, NSAID use during anticoagulation was associated with major bleeding at 6.5 versus 2.0 per 100 patient-years (HR 2.37, 1.51 to 3.75) [3]. The ibuprofen label notes that short-term studies did not show an effect on prothrombin time, but that bleeding has been reported and that warfarin plus an NSAID carries a higher risk of serious GI bleeding than either drug alone [2].
- Corticosteroids and alcohol. The ibuprofen label lists oral corticosteroids and alcohol use among the factors that raise the risk of NSAID-related stomach bleeding [2].
- Low-dose aspirin. Ibuprofen can blunt aspirin's antiplatelet effect, particularly when ibuprofen is taken before aspirin [2][7]. The label advises considering an NSAID that does not interfere, or a non-NSAID analgesic, for people taking aspirin for heart protection [2]. In a 2001 crossover study in healthy volunteers, ibuprofen 400 mg taken before aspirin 81 mg blocked aspirin's platelet inhibition, while acetaminophen and diclofenac did not [7].
- A second NSAID. Using ibuprofen and naproxen together, or any two NSAIDs, raises GI toxicity with little added benefit and is not recommended. The ibuprofen label likewise says ibuprofen with aspirin is not generally recommended because of the potential for increased adverse effects [2].
Doses and limits
On the Ozempic side, GI reactions rise with dose; in a separate 40-week trial, 2 mg produced GI reactions in 34% versus 30.8% on 1 mg, with no new safety signals [1]. On the NSAID side, the prescription ibuprofen label limits total daily use to 3,200 mg and recommends the lowest effective dose for the shortest duration consistent with treatment goals [2]. It also says to give ibuprofen with meals or milk if the stomach is upset [2].
Blood pressure and other medicines
The ibuprofen label says blood pressure should be monitored closely when an NSAID is started and throughout treatment, since NSAIDs can start or worsen hypertension, and that NSAIDs can blunt the effects of diuretics, ACE inhibitors and ARBs [2].
Check what you know
Question 1 of 5
Score: 0 right, 0 of 5 answered
Frequently asked questions
Can I take ibuprofen while on Ozempic?
Does naproxen carry the same risk as ibuprofen with Ozempic?
Does Ozempic change how ibuprofen is absorbed?
Can Ozempic and ibuprofen damage the kidneys together?
Does the risk change with the Ozempic dose?
Does acetaminophen interfere with aspirin the way ibuprofen does?
References
Show all 8 referencesHide references
- U.S. National Library of Medicine, DailyMed. Ozempic injection (Novo Nordisk) prescribing information. Ozempic injection (Novo Nordisk) label
- U.S. National Library of Medicine, DailyMed. Ibuprofen tablets Rx (generic) prescribing information. Ibuprofen tablets Rx (generic) label
- Davidson BL, Verheijen S, Lensing AW, Gebel M, Brighton TA, Lyons RM, et al. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin. JAMA Intern Med. 2014;174(6):947-53.
- Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024;391(2):109-121.
- Coxib and traditional NSAID Trialists' (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-79.
- Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525.
- Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001;345(25):1809-17.
- Dr. Mohammed Paika. 12 Things to NEVER Mix with Ozempic or Mounjaro. Accessed 2026-11-10.